Lexicon Pharmaceuticals(US:LXRX) Globenewswire·2025-03-04 21:15Core Insights - Lexicon Pharmaceuticals will release its fourth quarter and full year 2024 financial results on March 6, 2025, after market close [1] - A conference call and live webcast will be held at 5:00 p.m. ET on the same day to discuss the financial results and provide a business update [1][2] Company Overview - Lexicon Pharmaceuticals is a biopharmaceutical company focused on pioneering medicines that transform patients' lives [3] - The company utilizes the Genome5000™ program, a unique genomics target discovery platform, to study nearly 5,000 genes and identify over 100 protein targets with significant therapeutic potential [3] - Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in various therapeutic areas, including heart failure, neuropathic pain, obesity, cardiology, and diabetes [3]